Personal care major Johnson & Johnson is working with biotech specialist Sequential Skin to investigate whether there are any new markers for skin health, particularly those linked to acne and ageing.
Personal care major Johnson & Johnson (J&J) has reported a net profit dip for the full year and last quarter of 2022 amidst ongoing macroeconomic challenges, though its CEO remains focused on heavy R&D investment.
A round-up of CosmeticsDesign-Europe’s most-read news from January 2023 shows interest in expert insight on upcoming regulatory change, beauty tech launches, skin microbiome and botanicals science, and future consumer trends.
As the lines continue to blur between beauty and wellness products, Cosmetics Design-USA caught up with Neutrogena’s team of experts at CES about its innovative collaboration with UK-based wellness brand Nourished.
International beauty majors L’Oréal and Johnson & Johnson have launched smart beauty innovations in lipstick, brow care and skin supplements at this year’s CES tech tradeshow.
Personal care major Johnson & Johnson (J&J) has reported a rise in third quarter (Q3) sales and a surge in net profit, bolstered by strong growth in pharma and med tech but also solid results across its global consumer health business.
Personal care major Johnson & Johnson (J&J) has reported a rise in first half (H1) sales for 2022 despite a dip in pre-adjusted profits and consumer health sales hit by COVID-19, input costs and supply issues.
Johnson & Johnson (J&J) will become more competitive in personal care after the carve out of its consumer health business, particularly if it invests in personalised and premium NPD, an analyst says.
Personal care titan Johnson & Johnson (J&J) will split out its consumer health business to create a new publicly traded company, part of its wider plan to pursue more targeted growth strategies.
Personal care major Johnson & Johnson (J&J) has reported a significant surge in net earnings for the second quarter (Q2) of 2021, largely propelled by its medical device and pharma divisions, but consumer health also returned to growth.
Personal care major Johnson & Johnson (J&J) has reported a global sales rise for the first quarter of 2021, fuelled by pharmaceuticals and medical devices, but its consumer health division saw overall sales decline despite strength in oral and...
Personal care major Johnson & Johnson has reported a dip in full-year earnings for 2020 despite a sales lift for the last quarter but says it remains confident in the company’s broad-based strengths moving into 2021.
Imerys Talc America filed for bankruptcy the same month that US District Judge Freda Wolfson issued a ruling that allowed thousands of lawsuits against Johnson & Johnson to proceed. Now, the France-based industrial mineral company is selling its North...
The ongoing coronavirus (COVID-19) pandemic continues to challenge beauty business globally, and another look at the financials shows certain majors and categories continue to fare better than others.
Personal care major Johnson & Johnson has reported a lift in sales for its third quarter thanks to growth in its consumer health division, drawing the firm out of its previous Q2 plunge.
Personal care major Johnson & Johnson has outlined a range of measures in its ‘healthy lives mission’ program that aim to boost sustainability and improve the health of consumers over the next ten years.
Personal care major Johnson & Johnson has reported a sharp drop in net earnings across its global business for the second quarter of 2020 and a dip in sales across consumer health due to COVID-19.
The ongoing coronavirus (COVID-19) pandemic has changed the face of beauty business as we know it, and a dig into the financials shows some majors and categories have weathered the storm better than others.
The announcement comes less than one month after a judge’s ruling opened the door to thousands of lawsuits against the multinational medical and CPG company; but Johnson & Johnson attributes the decision to a COVID-19 portfolio assessment.
A ruling this week from US District Judge Freda Wolfson in New Jersey allows testimony from plaintiffs’ medical and scientific experts, including specialists in gynecologic oncology, cancer prevention research, and occupational and environmental health....
Personal care major Johnson & Johnson has lowered its 2020 guidance to reflect the impact of the ongoing coronavirus (COVID-19) crisis, despite a strong net income surge for the first quarter.
Personal care major Johnson & Johnson has reported stable full-year 2019 results, with marginal growth in consumer health driven largely by Neutrogena innovation despite a sales dip in baby care.
This week the consumer packaged goods company was order to pay millions to yet another woman who developed ovarian cancer following use of Johnson & Johnson’s talc products.
This week, a Missouri jury found the company liable for fraud, negligence, and conspiracy in a case brought by Jacqueline Fox and litigated by family members, following her death last October.
The USDA has confirmed that one of the products in the Johnson & Johnson’s Aveeno Baby Organic Harvest has lost NOP certification status on account of its formulation containing an unapproved ingredient.
Industry trade show in-cosmetics 2012 has won the ‘Best Trade Exhibition’ award the Event Awards ceremony thanks to its global reach and nine per cent growth In visitor attendance despite difficult economic times.
As SkinCare ingredients plans to open the doors on its 2012 edition on June 13, anti-ageing and sun care developments are high on the agenda for the educational programme.
Johnson & Johnson has released its third quarter results with its skin care, oral care and baby care categories sparing the blushes in the business’ Consumer segment.
Johnson & Johnson is the latest consumer goods company to come under fire from the UK's Advertising Standards Authority (ASA) for misleading advertising of their personal care products.
Johnson & Johnson (J&J) posted high fourth quarter sales
growth supported by a sharp rise in personal care sales that helped
the company achieve strong full year financial results.
Johnson & Johnson is said to be in advanced talks to buy up
Beijing-based Dabao Cosmetics - a move that could give the company
a valuable footing in what is currently a huge growth market.
New Jersey-based Johnson & Johnson has bought the Pfizer
healthcare division for $16.6bn in a deal that wins the company the
much sort after Listerine oral care brand.
The French subsidiary of Johnson & Johnson will acquire
Biapharm, a producer and marketer of skin care products centered on
the leading brand Biafine, at the end of September.
![J&J will combine its genomic database with data collected via Sequential Skin's skin patch tests to build out panels of skin health markers related to acne and ageing [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2023/03/15/johnson-johnson-sequential-skin-partnership-tracking-skin-health-markers-for-acne-and-ageing/16251070-1-eng-GB/Johnson-Johnson-Sequential-Skin-partnership-tracking-skin-health-markers-for-acne-and-ageing.jpg){kind=tracking}
![Johnson & Johnson remains on track to spin-off its consumer health division, featuring the Neutrogena brand among others [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/business-financial/johnson-johnson-2022-net-profit-dips-14-but-2023-guidance-remains-solid-albeit-prudent/16138406-1-eng-GB/Johnson-Johnson-2022-net-profit-dips-14-but-2023-guidance-remains-solid-albeit-prudent.jpg)
![The 3D-printed, seven-layered gummies could be customized to specific skin care goals and needs [Image: Nourished/Neutrogena]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign.com/article/2023/01/10/neutrogena-talks-nourished-skinstacks-supplement-launch-at-ces-2023/16072211-1-eng-GB/Neutrogena-talks-Nourished-Skinstacks-supplement-launch-at-CES-2023.jpg)
![L'Oréal has unveiled two prototype smart makeup application devices - one for lipstick and another for brows - both designed to make the category more inclusive and accessible [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2023/01/04/l-oreal-and-johnson-johnson-launch-smart-inclusive-beauty-devices-at-ces-tech-tradeshow-2023/16054832-1-eng-GB/L-Oreal-and-Johnson-Johnson-launch-smart-inclusive-beauty-devices-at-CES-tech-tradeshow-2023.jpg)
![Within J&J's consumer health business, its skin care brands Neutrogena and Aveena have performed strongly worldwide [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2022/10/20/johnson-johnson-q3-2022-net-profit-soars-21.6-with-worldwide-sales-up-and-guidance-maintained/15867791-1-eng-GB/Johnson-Johnson-Q3-2022-net-profit-soars-21.6-with-worldwide-sales-up-and-guidance-maintained.jpg)
![Supply constraints and inflationary pressures around input costs has continued to plague the global beauty and personal care category [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2022/07/28/johnson-johnson-q1-h2-2022-results-up-but-consumer-health-sales-dip-amid-supply-input-issues/15636276-1-eng-GB/Johnson-Johnson-Q1-H2-2022-results-up-but-consumer-health-sales-dip-amid-supply-input-issues.jpg)
![Johnson & Johnson's decision to spin-off its consumer health unit will create space for dedicated R&D investment in personal care, benefitting consumers [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2021/11/22/johnson-johnson-consumer-health-company-to-become-premium-competitive-business-says-globaldata/13032125-1-eng-GB/Johnson-Johnson-Consumer-Health-Company-to-become-premium-competitive-business-says-GlobalData.jpg)
![Johnson & Johnson plans to complete the carve-out of a standalone Consumer Health business by the end of 2022 [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/business-financial/johnson-johnson-splits-consumer-health-business-to-drive-growth/13016725-1-eng-GB/Johnson-Johnson-splits-consumer-health-business-to-drive-growth.jpg)
![Within the company's consumer health division, the skin health beauty franchise had performed particularly well along with baby care [Getty Images]](https://www.cosmeticsdesign-europe.com/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/business-financial/johnson-johnson-q2-2021-net-earnings-surge-with-consumer-health-back-to-growth/12669707-1-eng-GB/Johnson-Johnson-Q2-2021-net-earnings-surge-with-consumer-health-back-to-growth.jpg)
